RENO, Nev., Feb. 12, 2025 (GLOBE NEWSWIRE) -- Atlantis Casino Resort Spa's Atlantis Steakhouse and Spa Atlantis have earned the prestigious Forbes Travel Guide Four-Star Award, placing them on an exclusive list of properties recognized for luxurious offerings and exceptional guest service. This marks the 10th straight year Spa Atlantis has been honored as a Four-Star Award winner, while Atlantis Steakhouse is a second-time recipient of the industry-respected accolade.

Aflac Incorporated (NYSE:AFL ) Bank of America Securities 2025 Financial Services Conference February 12, 2025 10:30 AM ET Company Participants Dan Amos - Chairman and CEO David Young - Vice President of Capital Markets Conference Call Participants Josh Shanker - Bank of America Josh Shanker Joining today, we're at the Bank of America Financial Services Conference 2025. This session is going to be Aflac.

SAN FRANCISCO, CA / ACCESS Newswire / February 12, 2025 / Shares of electricity storage and software provider Fluence Energy, Inc. (NASDAQ:FLNC) closed down $6.07 (-46%) as the company continues to post declining revenue growth amid an ongoing SEC investigation into the company's alleged improper accounting practices. Hagens Berman is investigating whether Fluence Energy may have violated the U.S. securities laws and urges investors who suffered substantial losses to submit your losses now.

NEW YORK , Feb. 12, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Pacira BioSciences, Inc. (NASDAQ: PCRX) between August 2, 2023 and August 8, 2024, both dates inclusive (the "Class Period"), of the important March 14, 2025 lead plaintiff deadline. So what: If you purchased Pacira securities during the Class Period, you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Crocs, Inc. (NASDAQ:CROX) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/crocs-inc-lawsuit-submission-form?prid=129082&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your FTAI Aviation Ltd. (NASDAQ:FTAI) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/ftai-aviation-ltd-lawsuit-submission-form?prid=129083&wire=1 or contact Joseph E.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your Nextracker Inc. (NASDAQ:NXT) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/nextracker-inc-lawsuit-submission-form?prid=129084&wire=1 or contact Joseph E. Levi, Esq.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / If you suffered a loss on your ICON Public Limited Company (NASDAQ:ICLR) investment and want to learn about a potential recovery under the federal securities laws, follow the link below for more information: https://zlk.com/pslra-1/icon-public-limited-company-lawsuit-submission-form?prid=129085&wire=1 or contact Joseph E. Levi, Esq.

LOS ANGELES--(BUSINESS WIRE)-- #cre--Cushman & Wakefield (NYSE: CWK) announced today the appointment of Robert Thornburgh, SIOR, CCIM, FRICS as Regional President of the Southwest Region.

Olivier Blanchard notes rockiness in the chip trade but expects it to smooth out with the world's growing reliance on A.I. He anticipates companies to use the technology in ways that improve employee efficiency.

Patria Investments Limited (NASDAQ:PAX ) Q4 2024 Earnings Conference Call February 12, 2025 9:00 AM ET Company Participants Rob Lee - Head, Shareholder Relations Alex Saigh - Chief Executive Officer Ana Russo - Chief Financial Officer Conference Call Participants Beatriz de Abreu - Goldman Sachs William Barranjard - Itau BBA Ricardo Buchpiguel - BTG Pactual Operator Good day, and thank you for standing by. Welcome to the Patria Fourth Quarter and Full Year 2024 Earnings Conference Call.

ATLANTA, Feb. 12, 2025 (GLOBE NEWSWIRE) -- A shareholder class action lawsuit has been filed against Intellia Therapeutics, Inc. (“Intellia” or the “Company”) (NASDAQ: NTLA). The lawsuit alleges that Defendants made material misrepresentations concerning Intellia's Phase 1/2 study evaluating NTLA-3001 for the treatment of alpha-1 antitrypsin deficiency (AATD)-associated lung disease.

NEW YORK , Feb. 12, 2025 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of securities of Elastic N.V. (NYSE: ESTC) between May 31, 2024 and August 29, 2024, both dates inclusive (the "Class Period").

Canada Adventure Awaits: Stay 2+ Nights and Earn Wyndham Rewards Bonus Points Canada Adventure Awaits: Stay 2+ Nights and Earn Wyndham Rewards Bonus Points

Super Micro Computer Inc (NASDAQ:SMCI) may have delivered “softer uninspiring” preliminary quarterly results but there is a more robust future ahead highlighted by the company's $40 billion guidance for 2026 and the news its financial filing is in the works, analysts at Wedbush believe. Analysts repeated their ‘Neutral' rating on the stock but boosted their price target to $40 from $24 following the release of Super Micro's preliminary financial results for the fiscal second quarter after Tuesday's closing bell.

Rumble (RUM -3.76%) stock is slumping in Wednesday's trading. The company's share price was down 3.9% as of 3 p.m.

NEW YORK, NY / ACCESS Newswire / February 12, 2025 / Leading securities law firm Bleichmar Fonti & Auld LLP announces an investigation into Semtech Corp. (NASDAQ:SMTC) for potential violations of the federal securities laws. If you invested in Semtech, you are encouraged to obtain additional information by visiting https://www.bfalaw.com/cases-investigations/semtech-corp.

Rocket Pharmaceuticals, Inc.'s RP-L201 for LAD-I faces FDA rejection but shows promising data; potential approval could unlock a $350M market. RP-L102 for Fanconi Anemia and RP-A501 for Danon Disease show strong clinical data, indicating significant market potential. Financially, Rocket Pharma has a limited cash runway of 2–4 quarters, dependent on FDA approvals and successful public offerings.

NEW YORK , Feb. 12, 2025 /PRNewswire/ -- Why: Rosen Law Firm, a global investor rights law firm, announces an investigation of potential securities claims on behalf of shareholders of Celanese Corporation (NYSE: CE) resulting from allegations that Celanese may have issued materially misleading business information to the investing public. So What: If you purchased Celanese securities you may be entitled to compensation without payment of any out of pocket fees or costs through a contingency fee arrangement.

"We've got a great relationship with organized labor," says Lyft CEO David Risher https://trib.al/ExR4biN